Viagen
Animal cloning company
From Wikipedia, the free encyclopedia
Viagen Pets & Equine, based in Cedar Park, Texas, is a division of Colossal Biosciences that offers animal cloning services. Viagen's pets division was launched in 2016.[1]
| |
| Type | Division |
|---|---|
| Founded | 2002 |
| Headquarters | , United States |
| Parent | Colossal Biosciences |
| Website | viagenpets |
Technology and patents
Viagen offers cloning as well as DNA preservation services, sometimes called tissue or cell banking.[2]
Viagen's subsidiary Start Licensing owns a cloning patent which is licensed to their only competitor as of 2018, who also offers animal cloning services.[3] The cloning process used by both Viagen and their competitor is somatic cell nuclear transfer, as which was used for cloning Dolly the Sheep.[3]
History
Viagen was founded in Austin, Texas in 2002.[4] Viagen began by offering cloning to the livestock and equine industry in 2003,[1] and later included cloning of cats and dogs in 2016.[5]
In 2020, Viagen achieved the first successful cloning of an endangered species in the United States, the black-footed ferret.[6] As of 2025, Viagen had successfully cloned 15 species, including Przewalski’s horse.[6]
In November 2025, Viagen was acquired by Colossal Biosciences.[4][7]
